More joy for Indian generics as Roche loses major infringement case
Indian company Cipla has triumphed over Roche in Delhi’s high court in a decision that is likely to delight India’s booming generics manufacturing industry, while causing considerable alarm for multinationals in the pharma sphere.
The Swiss company…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.